ArticleAdvances in rheumatology (London, England)2023

Effectiveness and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a 52-week real-life study in an Italian cohort.

Francesco Molica Colella et al.PubMed ↗Publisher ↗

No numbers read from the abstract.